We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
TRADENAME TO BE CONFIRMED Seqirus Pty Ltd
Product name
TRADENAME TO BE CONFIRMED
Sponsor
Accepted date
Sep-2025
Active ingredients
Influenza virus haemagglutinin
Summary of proposed indication
Influenza virus haemagglutinin is a vaccine proposed for the active immunisation against influenza in persons 50 years of age and older.
Application type
A (new medicine)
Publication date
Sep-2025